Innovid Q2 2024 GAAP EPS $(0.07) Misses $(0.01) Estimate, Sales $37.951M Miss $38.650M Estimate
Portfolio Pulse from Benzinga Newsdesk
Innovid (NYSE:CTV) reported Q2 2024 GAAP EPS of $(0.07), missing the $(0.01) estimate by 600%. Sales were $37.951M, missing the $38.650M estimate by 1.81%. Despite the misses, losses improved by 50% YoY and sales increased by 9.86% YoY.
August 06, 2024 | 11:34 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Innovid (NYSE:CTV) reported Q2 2024 GAAP EPS of $(0.07), missing the $(0.01) estimate by 600%. Sales were $37.951M, missing the $38.650M estimate by 1.81%. Despite the misses, losses improved by 50% YoY and sales increased by 9.86% YoY.
Innovid's significant miss on EPS and slight miss on sales estimates are likely to negatively impact the stock price in the short term. However, the YoY improvement in losses and sales growth may provide some support.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100